High-dose argatroban for heparin-induced thrombocytopenia in a child using a ventricular assist device.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 23438563.
- Also identified by DOI 10.1016/j.athoracsur.2012.08.063.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 10-year-old boy who was receiving support from a ventricular assist device (VAD) experienced heparin-induced thrombocytopenia that was successfully treated with high-dose argatroban infusion to attain therapeutic activated partial thromboplastin time in spite of high serum argatroban levels. This case also highlights bolus argatroban dosing for VAD change in the setting of persistent ventricular fibrillation.
Medical subject headings
- Career Choice
- Hepacivirus
- Hepatitis C, Chronic
- Infectious Disease Transmission, Patient-to-Professional
- Internship and Residency